Go Pro

Ultragenyx Pharmaceutical (RARE) Institutional Ownership

Ultragenyx Pharmaceutical logo
$15.22 +0.47 (+3.19%)
Closing price 04:00 PM Eastern
Extended Trading
$15.20 -0.02 (-0.14%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

Current
Institutional Ownership
Percentage
97.67%
Number of
Institutional Buyers
(last 12 months)
182
Total
Institutional Inflows
(last 12 months)
$1.19B
Number of
Institutional Sellers
(last 12 months)
84
Total
Institutional Outflows
(last 12 months)
$518.73M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RARE Institutional Buying and Selling by Quarter

Ultragenyx Pharmaceutical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/2/2026Versant Capital Management Inc2,556$38K0.0%+121.9%0.003%
9/9/2026Engineers Gate Manager LP48,557$1.62M0.0%-45.7%0.049%
9/9/2026Integrated Wealth Concepts LLC9,318$311K0.0%N/A0.009%
9/9/2026IFP Advisors Inc2,313$77K0.0%+191.7%0.002%
9/9/2026Squarepoint Ops LLC338,368$11.30M0.0%-23.9%0.343%
9/8/2026Allworth Financial LP4,699$157K0.0%+130.9%0.005%
9/8/2026Arizona State Retirement System23,059$770K0.0%-3.3%0.023%
9/8/2026Nykredit A S4,615$154K0.0%N/A0.005%
8/27/2026Corient Private Wealth LP146,493$4.89M0.0%+7.3%0.149%
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al31,019$1.04M0.0%N/A0.031%
8/22/2026denkapparat Operations GmbH6,892$230K0.1%N/A0.007%
8/21/2026AXQ Capital LP33,800$1.13M0.1%-64.9%0.034%
8/21/2026Nykredit A S4,615$154K0.0%N/A0.005%
8/20/2026Headlands Technologies LLC25,305$845K0.1%-50.2%0.026%
8/20/2026Moore Capital Management LP128,035$4.28M0.1%-18.5%0.130%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC167,226$5.58M0.0%-25.0%0.170%
8/19/2026Hsbc Holdings PLC45,174$1.53M0.0%-12.5%0.046%
8/19/2026Wellington Management Group LLP1,250,464$41.75M0.0%-52.6%1.268%
8/18/2026Palo Alto Investors LP596,495$19.92M0.0%N/A0.605%
8/18/2026Jefferies Financial Group Inc.929,626$31.04M0.2%N/A0.943%
8/17/2026Capstone Investment Advisors LLC16,457$549K0.0%N/A0.017%
8/17/2026Corient Private Wealth LP139,094$4.64M0.0%N/A0.141%
8/17/2026Bank of America Corp DE1,148,454$38.35M0.0%N/A1.165%
8/15/2026Freestone Grove Partners LP1,861$62K0.0%N/A0.002%
8/15/2026Odyssean LLC122,087$4.08M0.7%+81.1%0.124%
8/15/2026Man Group plc195,110$6.52M0.0%N/A0.198%
8/15/2026Jupiter Topco LLC36,543$1.22M0.0%N/A0.037%
8/14/2026Hsbc Holdings PLC45,174$1.53M0.0%N/A0.046%
8/14/2026PDT Partners LLC15,405$514K0.0%N/A0.016%
8/14/2026Legal & General Group Plc586,520$19.58M0.0%N/A0.595%
8/14/2026The Manufacturers Life Insurance Company381,420$12.74M0.0%N/A0.387%
8/14/2026Algert Global LLC389,964$13.02M0.2%-9.0%0.396%
8/13/2026Sanctuary Advisors LLC6,204$207K0.0%N/A0.006%
8/13/2026Connor Clark & Lunn Investment Management Ltd.191,578$6.40M0.0%N/A0.194%
8/12/2026Commerce Bank12,058$403K0.0%N/A0.012%
8/12/2026Quantbot Technologies LP1,437$48K0.0%N/A0.001%
8/12/2026Landscape Capital Management L.L.C.6,682$223K0.0%N/A0.007%
8/12/2026Ieq Capital LLC106,026$3.54M0.0%N/A0.108%
8/11/2026Allworth Financial LP4,699$157K0.0%N/A0.005%
8/11/2026Blue Owl Capital Holdings LP182,638$6.10M0.9%N/A0.185%
A new kind of civil war is coming after election day? (Ad)

Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.tc pixel

Read Whitney Tilson's free analysis on what could happen next.
8/11/2026PCM Encore LLC6,306$211K0.0%N/A0.006%
8/11/2026E Fund Management Co. Ltd.14,334$479K0.0%N/A0.015%
8/10/2026Tocqueville Asset Management L.P.31,250$1.04M0.0%N/A0.032%
8/10/2026Eagle Health Investments LP884,121$29.52M4.9%N/A0.897%
8/7/2026BlackRock Inc.10,654,276$355.75M0.0%N/A10.818%
8/7/2026Pallas Capital Advisors LLC8,602$287K0.0%N/A0.009%
8/7/2026Deutsche Bank AG164,813$5.50M0.0%N/A0.167%
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.10,437$348K0.0%N/A0.011%
8/6/2026Bank of New York Mellon Corp470,697$15.72M0.0%N/A0.478%
8/6/2026Focus Partners Advisor Solutions LLC9,791$327K0.0%N/A0.010%
8/6/2026GSA Capital Partners LLP12,162$406K0.0%N/A0.012%
8/3/2026Oppenheimer Asset Management Inc.6,604$221K0.0%N/A0.007%
7/10/2026Handelsbanken Fonder AB39,523$1.32M0.0%+17.9%0.040%
7/9/2026Hennion & Walsh Asset Management Inc.25,456$850K0.0%-57.8%0.026%
7/8/2026Assenagon Asset Management S.A.120,864$4.04M0.0%-94.6%0.123%
7/7/2026GAMMA Investing LLC1,919$64K0.0%+149.5%0.002%
7/7/2026Harbor Investment Advisory LLC1,566$52K0.0%N/A0.002%
7/2/2026Versant Capital Management Inc1,152$38K0.0%+662.9%0.001%
6/3/2026Parallel Advisors LLC1,625$34K0.0%+778.4%0.002%
5/19/2026Bank of America Corp DE1,046,546$21.93M0.0%-13.8%1.063%
5/18/2026Amundi15,166$318K0.0%N/A0.015%
5/18/2026EverSource Wealth Advisors LLC2,167$45K0.0%+573.0%0.002%
5/18/2026California State Teachers Retirement System104,650$2.19M0.0%+25.6%0.106%
5/18/2026Royal Bank of Canada3,295$69K0.0%-98.0%0.003%
5/18/2026Rock Springs Capital Management LP1,218,773$25.53M1.5%-3.8%1.237%
5/18/2026Eagle Health Investments LP884,121$18.52M3.2%N/A0.898%
5/18/2026Eversept Partners LP62,575$1.31M0.1%-80.3%0.064%
5/16/2026The Manufacturers Life Insurance Company451,119$9.45M0.0%+36.2%0.458%
5/16/2026Quantinno Capital Management LP187,508$3.93M0.0%+276.9%0.190%
5/16/2026SummitTX Capital L.P.347,760$7.29M0.2%N/A0.353%
5/15/2026Entropy Technologies LP109,727$2.30M0.1%+80.9%0.111%
5/14/2026Renaissance Technologies LLC561,700$11.77M0.0%+53.4%0.570%
5/14/2026Pale Fire Capital SE16,514$346K0.0%+61.7%0.017%
5/14/2026Public Employees Retirement System of Ohio26,832$562K0.0%-3.3%0.027%
5/14/2026Knott David M Jr33,069$693K0.4%+65.3%0.034%
5/14/2026Sei Investments Co.92,094$1.93M0.0%-40.1%0.094%
5/13/2026First Trust Advisors LP14,198$297K0.0%-14.7%0.014%
5/8/2026PNC Financial Services Group Inc.11,050$231K0.0%+66.2%0.011%
5/7/2026Parallel Advisors LLC1,625$34K0.0%+778.4%0.002%
5/5/2026Bank of New York Mellon Corp341,125$7.15M0.0%+14.2%0.347%
5/1/2026Fifth Third Bancorp110,272$2.31M0.0%N/A0.112%
5/1/2026Candriam S.C.A.1,096,182$22.97M0.1%+37.1%1.115%
4/30/2026Hsbc Holdings PLC51,637$1.08M0.0%+74.0%0.053%
4/27/2026Y Intercept Hong Kong Ltd218,354$4.58M0.1%N/A0.222%
4/27/2026Leonteq Securities AG1,795$38K0.0%+288.5%0.002%
4/27/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.99,995$2.10M0.1%+63.0%0.102%
4/22/2026Pictet Asset Management Holding SA603,571$11.67M0.0%-51.0%0.614%
4/20/2026OP Asset Management Ltd86,917$1.82M0.0%N/A0.088%
4/20/2026Assenagon Asset Management S.A.2,257,671$47.30M0.1%+1,030.4%2.297%
4/16/2026SG Americas Securities LLC40,387$846K0.0%+25.4%0.041%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
3/20/2026Hsbc Holdings PLC29,679$663K0.0%-61.4%0.031%
3/17/2026Rockefeller Capital Management L.P.7,716$177K0.0%+611.8%0.008%
3/9/2026Flax Pond Capital LLC56,238$1.29M1.0%N/A0.058%
3/3/2026Caitong International Asset Management Co. Ltd122,854$2.83M0.7%+1,116,754.5%0.127%
2/19/2026Invesco Ltd.230,271$5.30M0.0%-71.0%0.239%
2/19/2026Alberta Investment Management Corp38,400$883K0.0%N/A0.040%
2/18/2026Mercer Global Advisors Inc. ADV13,965$321K0.0%+17.1%0.014%
2/18/2026Krensavage Asset Management LLC149,634$3.44M1.2%N/A0.155%
2/18/2026Empowered Funds LLC2,877$66K0.0%N/A0.003%
2/18/2026XTX Topco Ltd119,996$2.76M0.1%+734.8%0.124%


RARE Institutional Ownership - Frequently Asked Questions

During the previous two years, 329 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical. The most heavily invested institutionals were BlackRock Inc. ($355.75M), Vanguard Group Inc. ($236.07M), State Street Corp ($98.97M), Clearbridge Investments LLC ($97.70M), Baker BROS. Advisors LP ($87.55M), Sands Capital Management LLC ($80.17M), and RTW Investments LP ($69.00M).Learn more on Ultragenyx Pharmaceutical's institutional investors.

97.67% of Ultragenyx Pharmaceutical's stock is owned by institutional investors. Learn more on RARE's institutional investor holdings.

Of the 295 institutional investors that purchased Ultragenyx Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($10.65M), Norges Bank ($3.21M), Assenagon Asset Management S.A. ($3.16M), Eagle Health Investments LP ($1.90M), Jacobs Levy Equity Management Inc. ($1.86M), Vestal Point Capital LP ($1.50M), and Jefferies Financial Group Inc. ($1.41M).

Institutional investors have bought a total of 41,654,698 shares in the last 24 months. This purchase volume represents approximately $1.19B in transactions.

Of the 84 institutional investors that sold Ultragenyx Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($3.10M), Federated Hermes Inc. ($1.55M), Wellington Management Group LLP ($1.39M), Alliancebernstein L.P. ($1.23M), Deutsche Bank AG ($946.63K), Alyeska Investment Group L.P. ($897.44K), and Farallon Capital Management LLC ($891K).

Institutional investors have sold a total of 18,486,576 shares in the last 24 months. This volume of shares sold represents approximately $518.73M in transactions.



Institutional ownership data for NASDAQ:RARE is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/2/2026. New 13F filings are added each quarter as they're published.
From Our Partners